High-Throughput Screening Assays
"High-Throughput Screening Assays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.
| Descriptor ID |
D057166
|
| MeSH Number(s) |
E05.916.680
|
| Concept/Terms |
High-Throughput Screening Assays- High-Throughput Screening Assays
- Assay, High-Throughput Screening
- High Throughput Screening Assays
- High-Throughput Screening Assay
- Screening Assay, High-Throughput
- Screening Assays, High-Throughput
High-Throughput Screening Methods- High-Throughput Screening Methods
- High Throughput Screening Methods
- High-Throughput Screening Method
- Methods, High-Throughput Screening
- Screening Method, High-Throughput
- Screening Methods, High-Throughput
High-Throughput Biological Assays- High-Throughput Biological Assays
- Assay, High-Throughput Biological
- Assays, High-Throughput Biological
- Biological Assay, High-Throughput
- Biological Assays, High-Throughput
- High Throughput Biological Assays
- High-Throughput Biological Assay
High-Throughput Chemical Assays- High-Throughput Chemical Assays
- Assay, High-Throughput Chemical
- Assays, High-Throughput Chemical
- Chemical Assay, High-Throughput
- Chemical Assays, High-Throughput
- High Throughput Chemical Assays
- High-Throughput Chemical Assay
|
Below are MeSH descriptors whose meaning is more general than "High-Throughput Screening Assays".
Below are MeSH descriptors whose meaning is more specific than "High-Throughput Screening Assays".
This graph shows the total number of publications written about "High-Throughput Screening Assays" by people in this website by year, and whether "High-Throughput Screening Assays" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 4 | 6 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 3 | 5 |
| 2016 | 0 | 2 | 2 |
| 2017 | 3 | 2 | 5 |
| 2018 | 1 | 3 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "High-Throughput Screening Assays" by people in Profiles.
-
Zielinski JM, Luke JJ, Guglietta S, Krieg C. High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery. Front Immunol. 2021; 12:590742.
-
Otsuka Y, Airola MV, Choi YM, Coant N, Snider J, Cariello C, Saied EM, Arenz C, Bannister T, Rahaim R, Hannun YA, Shumate J, Scampavia L, Haley JD, Spicer TP. Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening. SLAS Discov. 2021 01; 26(1):113-121.
-
Walsh KB. Screening Technologies for Inward Rectifier Potassium Channels: Discovery of New Blockers and Activators. SLAS Discov. 2020 06; 25(5):420-433.
-
Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A, Faridi A, Parish CL, Ding F, Davis TP, Ke PC, Lin S. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun. 2019 08 22; 10(1):3780.
-
Dolloff NG. Discovery platform for inhibitors of IgH gene enhancer activity. Cancer Biol Ther. 2019; 20(4):571-581.
-
Robinson RM, Reyes L, Duncan RM, Bian H, Reitz AB, Manevich Y, McClure JJ, Champion MM, Chou CJ, Sharik ME, Chesi M, Bergsagel PL, Dolloff NG. Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma. Leukemia. 2019 04; 33(4):1011-1022.
-
Metz KS, Deoudes EM, Berginski ME, Jimenez-Ruiz I, Aksoy BA, Hammerbacher J, Gomez SM, Phanstiel DH. Coral: Clear and Customizable Visualization of Human Kinome Data. Cell Syst. 2018 09 26; 7(3):347-350.e1.
-
Voyton CM, Morris MT, Ackroyd PC, Morris JC, Christensen KA. FRET Flow Cytometry-Based High Throughput Screening Assay To Identify Disrupters of Glucose Levels in Trypanosoma brucei. ACS Infect Dis. 2018 07 13; 4(7):1058-1066.
-
Spencer-Smith R, O'Bryan JP. Direct inhibition of RAS: Quest for the Holy Grail? Semin Cancer Biol. 2019 02; 54:138-148.
-
Lee HW, Arif E, Altintas MM, Quick K, Maheshwari S, Plezia A, Mahmood A, Reiser J, Nihalani D, Gupta V. High-content screening assay-based discovery of paullones as novel podocyte-protective agents. Am J Physiol Renal Physiol. 2018 02 01; 314(2):F280-F292.